SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-142296
Filing Date
2019-05-09
Accepted
2019-05-09 08:11:56
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d717157d10q.htm 10-Q 784936
2 EX-31.1 d717157dex311.htm EX-31.1 6497
3 EX-31.2 d717157dex312.htm EX-31.2 6495
4 EX-32.1 d717157dex321.htm EX-32.1 4947
  Complete submission text file 0001193125-19-142296.txt   3153421

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mgta-20190331.xml EX-101.INS 417905
6 XBRL TAXONOMY EXTENSION SCHEMA mgta-20190331.xsd EX-101.SCH 32152
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20190331_cal.xml EX-101.CAL 45695
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20190331_def.xml EX-101.DEF 219718
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20190331_lab.xml EX-101.LAB 307521
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20190331_pre.xml EX-101.PRE 252890
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 19808878
SIC: 2834 Pharmaceutical Preparations